These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22367358)

  • 21. Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice.
    Llanga T; Nagy N; Conatser L; Dial C; Sutton RB; Hirsch ML
    Mol Ther; 2017 Sep; 25(9):2150-2162. PubMed ID: 28629822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal myoblast fusion requires myoferlin.
    Doherty KR; Cave A; Davis DB; Delmonte AJ; Posey A; Earley JU; Hadhazy M; McNally EM
    Development; 2005 Dec; 132(24):5565-75. PubMed ID: 16280346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of oxidative stress, nuclear factor kappa B and the ubiquitin proteasomal pathway in dysferlinopathy.
    Rajakumar D; Senguttuvan S; Alexander M; Oommen A
    Life Sci; 2014 Jul; 108(1):54-61. PubMed ID: 24846833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression.
    Wang B; Yang Z; Brisson BK; Feng H; Zhang Z; Welch EM; Peltz SW; Barton ER; Brown RH; Sweeney HL
    J Appl Physiol (1985); 2010 Sep; 109(3):901-5. PubMed ID: 20558759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysferlin and animal models for dysferlinopathy.
    Kobayashi K; Izawa T; Kuwamura M; Yamate J
    J Toxicol Pathol; 2012 Jun; 25(2):135-47. PubMed ID: 22907980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
    De Luna N; Gallardo E; Sonnet C; Chazaud B; Dominguez-Perles R; Suarez-Calvet X; Gherardi RK; Illa I
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):643-53. PubMed ID: 20467328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.
    Chiu YH; Hornsey MA; Klinge L; Jørgensen LH; Laval SH; Charlton R; Barresi R; Straub V; Lochmüller H; Bushby K
    Hum Mol Genet; 2009 Jun; 18(11):1976-89. PubMed ID: 19286669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fer1L5, a Dysferlin Homologue Present in Vesicles and Involved in C2C12 Myoblast Fusion and Membrane Repair.
    Usha Kalyani R; Perinbam K; Jeyanthi P; Al-Dhabi NA; Valan Arasu M; Esmail GA; Kim YO; Kim H; Kim HJ
    Biology (Basel); 2020 Nov; 9(11):. PubMed ID: 33182221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
    Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S
    Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
    J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity.
    de Morrée A; Hensbergen PJ; van Haagen HH; Dragan I; Deelder AM; 't Hoen PA; Frants RR; van der Maarel SM
    PLoS One; 2010 Nov; 5(11):e13854. PubMed ID: 21079765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
    Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
    PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental and tissue-specific regulation of a novel dysferlin isoform.
    Salani S; Lucchiari S; Fortunato F; Crimi M; Corti S; Locatelli F; Bossolasco P; Bresolin N; Comi GP
    Muscle Nerve; 2004 Sep; 30(3):366-74. PubMed ID: 15318348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy.
    Potter RA; Griffin DA; Sondergaard PC; Johnson RW; Pozsgai ER; Heller KN; Peterson EL; Lehtimäki KK; Windish HP; Mittal PJ; Albrecht DE; Mendell JR; Rodino-Klapac LR
    Hum Gene Ther; 2018 Jul; 29(7):749-762. PubMed ID: 28707952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice.
    Yasa J; Reed CE; Bournazos AM; Evesson FJ; Pang I; Graham ME; Wark JR; Nijagal B; Kwan KH; Kwiatkowski T; Jung R; Weisleder N; Cooper ST; Lemckert FA
    Acta Neuropathol Commun; 2023 Jan; 11(1):15. PubMed ID: 36653852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
    Cai C; Weisleder N; Ko JK; Komazaki S; Sunada Y; Nishi M; Takeshima H; Ma J
    J Biol Chem; 2009 Jun; 284(23):15894-902. PubMed ID: 19380584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.
    Han R; Frett EM; Levy JR; Rader EP; Lueck JD; Bansal D; Moore SA; Ng R; Beltrán-Valero de Bernabé D; Faulkner JA; Campbell KP
    J Clin Invest; 2010 Dec; 120(12):4366-74. PubMed ID: 21060153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferlin proteins in myoblast fusion and muscle growth.
    Posey AD; Demonbreun A; McNally EM
    Curr Top Dev Biol; 2011; 96():203-30. PubMed ID: 21621072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of myoferlin in skeletal muscles of patients with dysferlinopathy.
    Inoue M; Wakayama Y; Kojima H; Shibuya S; Jimi T; Oniki H; Nishino I; Nonaka I
    Tohoku J Exp Med; 2006 Jun; 209(2):109-16. PubMed ID: 16707852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.